Inhibition of aldose reductase prevents colon cancer metastasis

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1259-1267

  Tammali, Ravinder ^a   Reddy, Aramati B M ^a   Saxena, Ashish ^a   Rychahou, Piotr G ^a,c   Evers, B Mark ^a,c   Qiu, Suimin ^a   Awasthi, Sanjay ^b   Ramana, Kota V ^a   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; BINDING PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIDARESTAT; GELATINASE A; GREEN FLUORESCENT PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NUCLEAR FACTOR KAPPA BINDING PROTEIN; SMALL INTERFERING RNA; SORBINIL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; ZOPOLRESTAT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 79961176280     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr102     Document Type: Article

References (42)

1. American Cancer Society. (2010) Cancer Facts and Figures 2010. American Cancer Society, Atlanta, GA.
2. Gupta,G.P. et al. (2006) Cancer metastasis: building a framework. Cell, 127, 679-695.
3. Rychahou,P.G. et al. (2008) Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc. Natl Acad. Sci. USA, 105, 20315-20320.
4. Rychahou,P.G. et al. (2006) Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma. Ann. Surg., 243, 833-842.
5. Langley,R.R. et al. (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr. Rev., 28, 297-321.
6. Chambers,A.F. et al. (1995) Steps in tumor metastasis: new concepts from intravital video microscopy. Cancer Metastasis Rev., 14, 279-301.
7. Zetter,B.R. (1993) Adhesion molecules in tumor metastasis. Semin. Cancer Biol., 4, 219-229.
8. Jung,Y.D. et al. (2000) Role of the tumor microenvironment in mediating response to anti-angiogenic therapy. Cancer Metastasis Rev., 19, 147-157.
9. Fidler,I.J. et al. (1988) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim. Biophys. Acta, 948, 151-173.
10. Fidler,I.J. (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer, 3, 453-458.
11. Folkman,J. (2002) Role of angiogenesis in tumor growth and metastasis. Semin. Oncol., 29, 15-28.
12. Deryugina,E.I. et al. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev., 25, 9-34.
13. Mannello,F. et al. (2005) Matrix metalloproteinase inhibitors as anticancer therapeutics. Curr. Cancer Drug Targets, 5, 285-298.
14. Garg,A. et al. (2002) Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia, 16, 1053-1068.
15. Meyskens,F.L.Jr. et al. (1999) Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Clin. Cancer Res., 5, 1197-1202.
16. Sen,T. et al. (2009) Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci., 84, 194-204.
17. Yu,H. et al. (2008) Resveratrol inhibits tumor necrosis factor-alphamediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed. Pharmacother., 62, 366-372.
18. Huang,C.S. et al. (2007) Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem., 18, 449-456.
19. Zafarullah,M. et al. (2003) Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci., 60, 6-20.
20. Yang,C.S. et al. (2002) Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol., 42, 25-54.
21. Tammali,R. et al. (2006) Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res., 66, 9705-9713.
22. Tammali,R. et al. (2007) Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells. Cancer Lett., 252, 299-306.
23. Srivastava,S.K. et al. (2005) Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr. Rev., 26, 380-392.
24. Hers,H.G. (1956) The mechanism of the transformation of glucose in fructose in the seminal vesicles. Biochim. Biophys. Acta, 22, 202-203.
25. Ramana,K.V. et al. (2006) Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J. Biol. Chem., 281, 17652-17660.
26. Tammali,R. et al. (2009) Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation. Carcinogenesis, 30, 799-807.
27. Liang,C. et al. (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc., 2, 329-333.
28. Dianzani,C. et al. (2008) Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Br. J. Pharmacol., 153, 1153-1161.
29. Butts,C.L. et al. (2007) Evaluation of steroid hormone receptor protein expression in intact cells using flow cytometry. Nucl. Recept. Signal., 5, 1-6.
30. Feig,D.I. et al. (1994) Reactive oxygen species in tumorigenesis. Cancer Res., 54, 1890s-1894s.
31. Ushio-Fukai,M. et al. (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett., 266, 37-52.
32. Nishikawa,M. et al. (2005) Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J. Control. Release, 109, 101-107.
33. Liu,Q. et al. (2009) Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. Phytomedicine, 16, 916-922.
34. Ramana,K.V. et al. (2005) Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes, 54, 818-829.
35. Naugler,W.E. et al. (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr. Opin. Genet. Dev., 18, 19-26.
36. Tremblay,P.L. et al. (2006) Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene, 25, 6563-6573.
37. Zeindl-Eberhart,E. et al. (1994) Identification of tumor-associated protein variants during rat hepatocarcinogenesis, aldose reductase. J. Biol. Chem., 269, 14589-14594.
38. Saraswat,M. et al. (2006) Overexpression of aldose reductase in human cancer tissues. Med. Sci. Monit., 12, CR525-CR529.
39. Giatromanolaki,A. et al. (2006) Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am. J. Clin. Oncol., 29, 408-417.
40. Tammali,R. et al. (2011) Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. Angiogenesis DOI 10.1007/s10456-011-9206-4.
41. Giavazzi,R. et al. (1986) Experimental nude mouse model of human colorectal cancer liver metastases. J. Natl Cancer Inst., 77, 1303-1308.
42. Giavazzi,R. et al. (1986) Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res., 46, 1928-1933.